Knowledge Center
Patent / Jan 01, 2013
Application of high dose compounds via inhalation for treatment of pulmonary diseases
Source:
WO 2013104892
The invention relates to the delivery of high doses of active pharmaceutical compds. via inhalation for the treatment of pulmonary diseases. A pharmaceutical formulation in the form of a powder suitable for inhalation comprises one or more active pharmaceutical ingredients, such as an antibiotic, a mucolytic agent and/or a buffer, wherein the formulation is free of carrier. A powder formulation comprising doxycycline monohydrate combined with sodium citrate filled into TwinCap devices was exemplified.
Also in the Knowledge Center
/ Oct 19, 2026
A dimensionless framework for hold-up mass prediction and scale transfer in continuous linear blending
Read more
Scientific Article
/ Oct 26, 2026
Streamlined development of continuous blending through integrated process understanding and predictive modeling
Read more
Scientific Article
/ Aug 04, 2026
Hovione: Accelerating Oral Drug Development Through Rapid Prototyping and Integrated Development Strategies
Read more
Scientific Article